Calmsie - Children's mental health
Calmsie, a pioneer in the digital therapeutics for children's mental health, faced the challenge of optimizing its study landscape and patient enrollment strategies for its digital solutions in both the US and Europe. Understanding the right patient cohorts and securing sufficient enrollment numbers were critical for advancing the effectiveness and reach of Calmsie's therapeutic tools.
Headquarters
San Francisco, California, United States
Founded
2020
Stage
Series A
Clinical Stage
Medical device
Challenge
Calmsie, a pioneer in the digital therapeutics for children's mental health, faced the challenge of optimizing its study landscape and patient enrollment strategies for its digital solutions in both the US and Europe. Understanding the right patient cohorts and securing sufficient enrollment numbers were critical for advancing the effectiveness and reach of Calmsie's therapeutic tools.
Results
By utilizing the Neuroute platform for a comprehensive understanding of patient cohorts, existing study landscapes, and enrollment data, Calmsie successfully optimized its patient enrollment strategies. As a result, Calmsie witnessed a 25% increase in study enrollment and a more diverse patient base, ensuring a broader applicability of their digital therapeutic tools.
Indications
Studies analyzed
Process
Patient Cohort Analysis: The first step involved leveraging the Neuroute platform to conduct an exhaustive analysis of patient cohorts specific to children's mental health issues like ADHD, Anxiety Disorders, and Mood Disorders. Calmsie utilized Neuroute's data analytics to understand the demographics, prevalence rates, and geographical spread of these conditions across the US and Europe.
Landscape Analysis: For this crucial step, Calmsie utilized Neuroute’s capabilities to analyze existing studies, treatment protocols, and digital therapeutic options currently available in the US and Europe. This helped identify gaps in the market and areas where Calmsie's solutions could bring the most impact.
Enrollment Analysis: Calmsie then utilized the Neuroute platform to study enrollment patterns in similar research efforts. Understanding these metrics helped Calmsie adjust its recruitment strategy to be more effective and efficient.
Enrollment Modelling: Incorporating insights gathered from the first three steps, Calmsie formulated a robust patient enrollment strategy, again utilizing Neuroute's analytics features to predict which enrollment channels and methods would yield the best outcomes.
Conclusion
Calmsie's collaboration with the Neuroute platform proved instrumental in shaping a more effective and targeted approach towards patient enrollment and study design in the challenging field of children's mental health. The insights derived enabled Calmsie to fortify its position as a leader in digital therapeutics for children, thereby fulfilling its mission to improve mental health outcomes for younger populations in both the US and Europe.
